LRRC3B and cancer: Altogether, we conclude that LRRC3B silencing by DNA methylation at the promoter region induces tumor escape from immune surveillance by decreasing levels of anti-tumor cells in the TME, inhibiting regulation of cell killing, increasing the levels of pro-tumor cells in the TME, and promoting cancer cell proliferation.